Information

You are on the new improved site. You can view the old site in view-only mode here until June 27, 2026

loading
Treatment of Patients with Severe Combined Immunodeficiency due to Adenosine Deaminase (ADA) Deficiency by Autologous Transplantation of Genetically Modified Bone Marrow Cells. University Hospital Leiden and Institute of Applied Radiobiology and Immunology TNO,The Netherlands